Literature DB >> 22019034

B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections.

T A Schlager1, Robin LeGallo, D Innes, J O Hendley, C A Peters.   

Abstract

PURPOSE: We defined chronic inflammatory cell types in bladder submucosa and the presence of umbrella cells on the surface of bladder epithelium in patients 5 to 21 years old with persistent bacteriuria due to neurogenic bladder and recurrent urinary tract infections associated with vesicoureteral reflux.
MATERIALS AND METHODS: Bladder mucosa biopsies from 12 patients and 6 controls were fixed in Carnoy's solution and examined for T cells (CD3, CD4, CD8), B cells (CD79) and plasma cells (CD138). The number of cells in a defined area of submucosa was determined by counting all nuclei in the area. A contiguous section was also stained for uroplakin expression with a monoclonal antibody against uroplakin III to ascertain the integrity of bladder umbrella cells.
RESULTS: B cells, plasma cells and lymphoid nodules were found only in patient biopsies. T cell expression was evident in patient and control biopsies. Uroplakin staining of surface epithelium was uniform from control biopsies but spotty or entirely absent from patient biopsies.
CONCLUSIONS: Patients with persistent bacteriuria or recurrent urinary tract infections had significant B cell infiltration in the submucosa, including lymphoid nodules. These inflammatory changes are likely due to antigenic stimulation from repeated exposure to bacteria. These changes are associated with frequent absence of uroplakin on surface epithelium. Copyright Â
© 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22019034     DOI: 10.1016/j.juro.2011.07.114

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.

Authors:  Roger D Klein; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2020-02-18       Impact factor: 60.633

3.  One size doesn't fit all: unraveling the diversity of factors and interactions that drive E. coli urovirulence.

Authors:  Henry L Schreiber; Caitlin N Spaulding; Karen W Dodson; Jonathan Livny; Scott J Hultgren
Journal:  Ann Transl Med       Date:  2017-01

4.  A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease.

Authors:  Valerie P O'Brien; Thomas J Hannan; Lu Yu; Jonathan Livny; Elisha D O Roberson; Drew J Schwartz; Spenser Souza; Cathy L Mendelsohn; Marco Colonna; Amanda L Lewis; Scott J Hultgren
Journal:  Nat Microbiol       Date:  2016-10-31       Impact factor: 17.745

Review 5.  The unexplored relationship between urinary tract infections and the autonomic nervous system.

Authors:  Michael E Hibbing; Matt S Conover; Scott J Hultgren
Journal:  Auton Neurosci       Date:  2015-06-06       Impact factor: 3.145

Review 6.  Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.

Authors:  Valerie P O'Brien; Thomas J Hannan; Anthony J Schaeffer; Scott J Hultgren
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

7.  A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology.

Authors:  Floriane Michel; Fabiana Cancrini; Géraldine Cancel-Tassin; Xavier Gamé; Eric Huyghe; Aurélien Rock; Grégoire Léon; Audrey Uzan; François-Régis Desfemmes; Benoît Peyronnet; Jérémy Fallot; Priscilla Léon; Emmanuel Rolland; Marie-Aimée Perrouin-Verbe; Jacques Wodey; Grégoire Capon; Gilles Karsenty; Morgan Rouprêt; Olivier Cussenot; Hussa Alshehhi; Eva Comperat; Véronique Phé
Journal:  World J Urol       Date:  2022-02-09       Impact factor: 3.661

8.  Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?

Authors:  Fabiana Cancrini; Floriane Michel; Olivier Cussenot; Hussa Alshehhi; Eva Comperat; Véronique Phé
Journal:  World J Urol       Date:  2022-01-29       Impact factor: 3.661

9.  Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.

Authors:  Matt S Conover; Ségolène Ruer; Joemar Taganna; Vasilios Kalas; Henri De Greve; Jerome S Pinkner; Karen W Dodson; Han Remaut; Scott J Hultgren
Journal:  Cell Host Microbe       Date:  2016-09-22       Impact factor: 21.023

10.  Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.

Authors:  Thomas J Hannan; Pacita L Roberts; Terrence E Riehl; Sjoerd van der Post; Jana M Binkley; Drew J Schwartz; Hiroyuki Miyoshi; Matthias Mack; Reto A Schwendener; Thomas M Hooton; Thaddeus S Stappenbeck; Gunnar C Hansson; William F Stenson; Marco Colonna; Ann E Stapleton; Scott J Hultgren
Journal:  EBioMedicine       Date:  2014-10-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.